Drug Trial Radar · NCT00421993
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Feb 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,670
Actual
Start
Oct 2006
Primary completion
Oct 2007
Study completion Dec 2007
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Jan 15, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-blind, parallel group study with 12 weeks of treatment of acne vulgaris. Efficacy and safety evaluations will be performed at Screening (safety only), Baseline and Weeks 1, 2, 4, 8 and 12. All Investigator's Global Assessment evaluators and lesion counters must be trained and approved by Galderma. The evaluator of a subject should remain the same during the study. The primary objective is to demonstrate the superiority in efficacy and assess safety of Adapalene/Benzoyl Peroxide Topical Gel (Adapalene/Benzoyl Peroxide Gel) versus Adapalene Topical Gel, 0.1% (Adapalene Monad); Benzoyl Peroxide Topical Gel, 2.5% (Benzoyl Peroxide Monad) and Topical Gel Vehicle (Gel Vehicle) in the treatment of acne vulgaris for up to 12 weeks.
Conditions
- Acne Vulgaris
Interventions
Adapalene/Benzoyl PeroxideDrug
Topical Gel, One application daily in the evening for 12 weeks
AdapaleneDrug
Topical Gel,One application daily in the evening for 12 weeks
Benzoyl PeroxideDrug
Topical Gel, one application daily in the evening for 12 weeks
Topical Gel VehicleDrug
Topical Gel Vehicle,one application daily in the evening for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success Rate on the Investigator's Global AssessmentTime frame: at week 12
- Changes in Inflammatory Lesion CountsTime frame: from Baseline to week 12
- Changes in Noninflammatory Lesion CountsTime frame: from Baseline to week 12
Locations
62 sites in 5 countries. Site status is shown where the registry gives one.
Medical Affliated Research Center
Huntsville, Alabama
Dermatology Research of Arkansas
Little Rock, Arkansas
Associates in research, Inc.
Fresno, California
University of California, Irvine
Irvine, California
Dermatology Research Associates
Los Angeles, California
Marcia J. Glenn, MD and Associates, Dermatology & Laser center, Inc
Marina del Rey, California
Affiliated Research Institute
San Diego, California
University at San Francisco Medical Center
San Francisco, California
Radiant Research
Santa Rosa, California
Dr Weintraub James
Simi Valley, California
The George Washington University Medical Center
Washington D.C., District of Columbia
Visions Clinical Research
West Palm Beach, Florida
Atlanta Dermatology and Vein Research Center
Alpharetta, Georgia
SKINQRI
Lincolnshire, Illinois
Welborn Clinic
Evansville, Indiana
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Dolby Research, LLC
Baton Rouge, Louisiana
Hamzavi Dermatology
Port Huron, Michigan
Somerset Skin Clinic
Troy, Michigan
James Del Rosso, DO - Office of Dr. James Del Russo
Henderson, Nevada
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Skin Specialty Group
New York, New York
Derm Research Center of NY, Inc.
Stony Brook, New York
Zoe Draelos
High Point, North Carolina
OU Health Sciences Center - Dept. of Dermatology
Oklahoma City, Oklahoma
Allergy, Asthma and Dermatology Research Center, LLC
Lake Oswego, Oregon
Radiant Research
Anderson, South Carolina
Dermatology Associates of Knoxville
Knoxville, Tennessee
Arlington Center for Dermatology
Arlington, Texas
UTSW Medical Center at Dallas
Dallas, Texas
University of Texas Medical Branch at Galveston
Galveston, Texas
Tanner Clinic
Layton, Utah
Fletcher Allen Health Care
Burlington, Vermont
The Dermatology Centre
Calgary, Alberta, Canada
Stratica Medical
Edmonton, Alberta, Canada
Guildford Dermatology Specialists
Surrey, British Columbia, Canada
Derm Research @ 888 Inc.
Vancouver, British Columbia, Canada
Winnipeg Clinic
Winnipeg, Manitoba, Canada
Dermadvances Research
Winnipeg, Manitoba, Canada
Nexus clinical research
St. John's, Newfoundland and Labrador, Canada
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.